| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 2516 |
| 1 | EXENATIDE | 1523 |
| 2 | ADALIMUMAB | 936 |
| 3 | USTEKINUMAB | 824 |
| 4 | METFORMIN | 624 |
| 5 | METFORMIN ER 500 MG | 588 |
| 6 | METFORMIN ER 750 MG | 588 |
| 7 | ABATACEPT | 566 |
| 8 | GOLIMUMAB | 549 |
| 9 | GUSELKUMAB | 521 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AESCULUS HIPPOCASTANUM, BUD, CAL PHOS, CARPINUS BETULUS, FLOS, KALI PHOS, MAG PHOS, NAT MUR, NAT SULPH, ULMUS PROCERA, FLOS | 2 | 0.1818 |
| 1 | OCTREOTIDE ACETATE | 2516 | 0.0996 |
| 2 | ARIPIPRAZOLE LAUROXIL | 327 | 0.0975 |
| 3 | TRIPTORELIN | 142 | 0.0735 |
| 4 | LONAPEGSOMATROPIN-TCGD | 3 | 0.0577 |
| 5 | AMCINONIDE | 4 | 0.0494 |
| 6 | PANCREATIN | 52 | 0.0493 |
| 7 | GUSELKUMAB | 521 | 0.0423 |
| 8 | PEGVISOMANT | 122 | 0.0402 |
| 9 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0385 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 1653 |
| 1 | Interleukin-23 Antagonist [EPC] | 1363 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 1281 |
| 3 | Interleukin-12 Antagonist [EPC] | 824 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 566 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 544 |
| 6 | Insulin Analog [EPC] | 541 |
| 7 | Corticosteroid [EPC] | 538 |
| 8 | Interleukin-17A Antagonist [EPC] | 514 |
| 9 | Interleukin-4 Receptor alpha Antagonist [EPC] | 454 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 5 | 0.0205 |
| 1 | Interleukin-23 Antagonist [EPC] | 1363 | 0.0146 |
| 2 | Human Immunoglobulin G [EPC] | 77 | 0.0129 |
| 3 | Leptin Analog [EPC] | 10 | 0.0122 |
| 4 | Parathyroid Hormone-Related Peptide Analog [EPC] | 143 | 0.0120 |
| 5 | Interleukin-12 Antagonist [EPC] | 824 | 0.0118 |
| 6 | Ergot Derivative [EPC] | 37 | 0.0102 |
| 7 | Gonadotropin [EPC] | 13 | 0.0100 |
| 8 | Somatostatin Analog [EPC] | 36 | 0.0088 |
| 9 | GLP-2 Analog [EPC] | 70 | 0.0085 |